Navigation Links
Rothwell, Wolf Elected to Codexis Board
Date:12/12/2007

REDWOOD CITY, Calif., Dec. 12 /PRNewswire/ -- Codexis, Inc., a leading developer of clean technology manufacturing processes, today announced two new directors have been named to the company's Board of Directors. Joining the Board are Bill Rothwell, Ph.D., Vice President of Innovation and Chemicals Technology, Shell Global Solutions, a unit of Royal Dutch Shell plc and Dennis Wolf, Executive Vice President and CFO, MySQL, a leading open source database company.

"Our new directors bring valuable expertise to Codexis at an important point in our company's growth," said Alan Shaw, Ph.D., President and Chief Executive Officer. "Bill Rothwell has nearly 30 years experience managing and leading technology innovation at Shell. He joins us as part of our extended collaboration with Shell in biofuels, announced November 6. Dennis Wolf, a seasoned finance executive in high growth public technology companies, will bring Codexis valuable experience and perspective. We are very pleased to welcome both of them to our Board."

Dr. Rothwell is based in Houston and has global responsibility for identifying and leveraging innovation and chemical technology across the Shell Group, including all biodomain research. He sits on both the Shell Global Solutions and Shell Chemicals Leadership Teams. He has a strong technical background combined with extensive experience in strategy and business roles. He joined Shell in 1980 with a Ph.D. in physical chemistry from the Massachusetts Institute of Technology and has undergraduate degrees in mathematics and chemistry from Michigan State University.

In his first decade at Shell, Dr. Rothwell worked as a research manager and research chemist at the Westhollow Technology Centre in Houston. In 1990 he moved to Shell's offices in Houston and over the next seven years worked in a number of strategic planning and business assignments. In 1998 he relocated to London and served as Head of Strategy, Planning and Ventures for Shell Chemicals. In 2002, he was appointed to the position of General Manager of Shell Chemicals global Ethylene Oxide/Glycols business, a position he held until his current appointment earlier this year.

Mr. Wolf has broad executive financial management experience in technology companies at the COO, CFO and Co-CEO level. He currently serves as Executive Vice President and CFO at MySQL, AB, Cupertino, CA. The company produces a leading open source database used by customers to power high volume websites and other business-critical functions. Mr. Wolf is responsible for managing the company's finance operations. Previously, he held financial management positions for public high technology companies including Omnicell, Inc., Credence Systems, Centigram, Apple Computer and Sun Microsystems.

Mr. Wolf holds a bachelor of arts degree from the University of Colorado and an MBA from the University of Denver. He currently serves on the board of Quantum and has been a board member and chair of the audit committee for Nasdaq-listed companies including Komag, Vitria Technology and Registry Magic.

Codexis, Inc. is a leading developer of clean biocatalytic process technologies that can substantially reduce the cost of manufacturing across a broad range of industries. Codexis' proprietary directed evolution technologies enable novel solutions for efficient, cost-effective and environmentally friendly processes for pharmaceutical, energy and industrial chemical applications. In 2006, the company was recognized by the U.S. EPA with a Presidential Green Chemistry Challenge Award. Codexis is a registered trademark of Codexis, Inc. For more information please visit http://www.codexis.com

Contact: Justin Jackson, jjackson@burnsmc.com of Burns McClellan, 212-213-0006, or Lyn Christenson, Codexis, lyn.christenson@codexis.com, 650-421-8144.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Pasternack Elected to Codexis Board
2. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
3. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
4. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
7. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
8. Solazyme Selected for National Institute of Standards and Technology Award
9. Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of America
10. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
11. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... 2017 UCHealth ( Aurora, Colorado ... pulmonary nodule patient management. In addition to optimizing care ... on the lung, UCHealth looks to improve provider workflow ... Stephanie Brown, RN , Thoracic Nurse ... with an Excel spreadsheet, which was extremely arduous and ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced today ... and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews ... female physician suffering from degenerative disc disease with radiculomyelopathy, as a result of ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
(Date:2/1/2017)... February 1, 2017 IDTechEx Research, a leading ... technology, announces the availability of a new report, Sensors for ... Continue Reading ... ... collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and ...
Breaking Biology News(10 mins):